Anti-Helicobacter pylori treatment in bleeding ulcers: Randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy

American Journal of Gastroenterology

Volumn 92, Issue 3, 1997, Pages 438-441

  Kung, Nelson N S ^b   Sung, Joseph J Y ^a   Yuen, Nancy W F ^b   Ng, P W ^b   Wong, Kin Chung ^b   Chung, Edward C H ^b   Lim, B H ^b   Choi, C H ^b   Li, Ting Ho ^b   Ma, H C ^b   Kwok, Samuel P Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH CITRATE; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ADULT; AGED; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MIXTURE; DRUG SCREENING; DUODENUM BLEEDING; FEMALE; GASTRODUODENAL ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH HEMORRHAGE; ULCER HEALING; VOMITING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; BISMUTH; DRUG ADMINISTRATION SCHEDULE; DUODENAL ULCER; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOSPITALIZATION; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PATIENT COMPLIANCE; PEPTIC ULCER HEMORRHAGE; STOMACH ULCER; TETRACYCLINE;

EID: 18244415477     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Labenz J, Borsch G. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994;89:1785-8.
2. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomised, controlled study. Ann Intern Med 1992;116:705-8.
3. Sung JJY, Chung SCS, Ling TKW, et al. One year follow-up of duodenal ulcers after 1-week triple therapy for Helicobacter pylori. Am J Gastroenterol 1994;89:199-202.
4. Jaspersen D, Koemer T, Schorr W, et al. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer haemorrhage. Gastrointest Endosc 1995;41:5-7.
5. Labenz J, Borsch G. Role of helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994;55:19-23.
6. Graham DY, Hepps KS, Ramirez FC, et al. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-42.
7. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomised controlled trial. Lancet 1994;343:508-10.
8. Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Eng J Med 1995; 332:139-42.
9. Kimura K, Ido K, Saifuku K, et al. A 1-hr Topical therapy for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90:60-3.
10. Tucci A, Poli L, Mazzoni C, et al. Week-end therapy for H. pylori infection. Gastroenterology 1995;108:A246 (abstract).
11. Tucci A, Corinaldesi R, Stanghellini V, et al. One day therapy for treatment of Helicobacter pylori. Dig Dis Sci 1993;38:1670-3.
12. Forrest JA, Finlayson NDC, Shearman DJC. Endoscopy in gastrointestinal bleeding. Lancet 1974;ii:394.
13. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-6.
14. Penston JG. Helicobacter pylori eradication: Understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994;8:359-68.
15. El-Zimaity HMT, Al-Assi MT, Genta RM, et al. Confirmation of successful therapy of Helicobacter pylori infection: Number and site of biopsies or a rapid urease test. Am J Gastroenterol 1995;90:1962-4.
16. Marshall BJ, Warren JR, Francis GJ, et al. Rapid urease test in the management of Campylobacter priori-associated gastritis. Am J Gastroenterol 1987;82:200-10.
17. de Boer WA, Driessen WMM, Potters HVPJ, et al. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori. Am J Gastroenterol 1994;89:1993-7.
18. de Boer WA, Driessen W, Jansz A, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995; 345:817-20.
19. Ling TKW, Cheng AFB, Sung JJY, et al. An increase in prevalence of metronidazole-resistant Helicobacter pylori after using triple therapy: A five year study. Helicobacter 1996;1:57-61.
20. Xia H, Keane CT, Beattie S, et al. Standardization of disk diffusion test and its clinical significance for susceptibility of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother 1994;38:2357-61.
21. Borody TJ, Andrews P, Fracchia G, et al. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995; 37:477-81.
22. de Boer WA, Driessen WMM, Tytgat GNJ. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:633-8.